Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection. The DEDALO project
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection. The DEDALO project
Authors
Keywords
-
Journal
Andrology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-12
DOI
10.1111/andr.12837
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020
- (2020) Licia Bordi et al. Eurosurveillance
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
- (2020) M. Montopoli et al. ANNALS OF ONCOLOGY
- COVID-19 infection: the perspectives on immune responses
- (2020) Yufang Shi et al. CELL DEATH AND DIFFERENTIATION
- Androgen sensitivity gateway to COVID ‐19 disease severity
- (2020) Carlos Gustavo Wambier et al. DRUG DEVELOPMENT RESEARCH
- Clinical course and mortality risk of severe COVID-19
- (2020) Paul Weiss et al. LANCET
- Could nasal nitric oxide help to mitigate the severity of COVID-19?
- (2020) Jan Martel et al. MICROBES AND INFECTION
- Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19
- (2020) Jiewen Fu et al. MOLECULAR BIOLOGY REPORTS
- Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab
- (2020) D. Paoli et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
- (2020) Peter M George et al. Lancet Respiratory Medicine
- Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target
- (2020) Michael J. Hughes et al. European Respiratory Review
- SARS-CoV-2 and the testis: similarity with other viruses and routes of infection
- (2020) Walter D. Cardona Maya et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
- (2020) Andrea M Isidori et al. Lancet Diabetes & Endocrinology
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019
- (2020) Diangeng Li et al. JAMA Network Open
- Treatment of severe idiopathic pulmonary fibrosis—is sildenafil the next (in)stage?
- (2019) Conal Hayton et al. Journal of Thoracic Disease
- PDE5 inhibition stimulates Tie2-expressing monocytes and Angiopoietin-1 restoring angiogenic homeostasis in diabetes
- (2019) Mary Anna Venneri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sildenafil Reduces Neointimal Hyperplasia after Angioplasty and Inhibits Platelet Aggregation via Activation of cGMP-dependent Protein Kinase
- (2019) Han-Mo Yang et al. Scientific Reports
- Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
- (2018) David Charles Hutchings et al. HEART
- Chronic phosphodiesterase type 5 inhibition has beneficial effects on subcutaneous adipose tissue plasticity in type 2 diabetic mice
- (2018) Daniela Fiore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study – Rationale and study design
- (2018) Jürgen Behr et al. RESPIRATORY MEDICINE
- Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation
- (2017) Marco Guazzi EUROPEAN JOURNAL OF HEART FAILURE
- Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7
- (2017) Riccardo Pofi et al. Scientific Reports
- Is there a role for sildenafil in the management of paraquat-induced lung fibrosis?
- (2016) Sayed Mahdi Marashi et al. Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology
- Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial
- (2016) Daniele Santi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: anex vivo/in vitrostudy
- (2016) Javier Milara et al. EUROPEAN RESPIRATORY JOURNAL
- Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science
- (2016) Paul M. Hassoun et al. EUROPEAN RESPIRATORY JOURNAL
- Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
- (2016) Simon G Anderson et al. HEART
- PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial
- (2016) Daniela Fiore et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients?
- (2015) Antonio Aversa et al. EXPERT OPINION ON PHARMACOTHERAPY
- Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes
- (2015) Elisabetta Mandosi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Erectile dysfunction and its management in patients with diabetes mellitus
- (2015) Giuseppe Defeudis et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice
- (2015) Mary Anna Venneri et al. PLoS One
- Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload
- (2014) Marinus A. Borgdorff et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials
- (2014) Elisa Giannetta et al. BMC Medicine
- Testosterone Supplementation and Sexual Function: A Meta-Analysis Study
- (2014) Giovanni Corona et al. Journal of Sexual Medicine
- Effect of Testosterone Replacement on Response to Sildenafil Citrate in Men With Erectile Dysfunction
- (2013) Matthew Spitzer et al. ANNALS OF INTERNAL MEDICINE
- Effects of Testosterone Replacement on Response to Sildenafil Citrate
- (2013) Antonio Aversa et al. ANNALS OF INTERNAL MEDICINE
- Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy
- (2012) Elisa Giannetta et al. CIRCULATION
- Sildenafil Plasma Concentrations in Two HIV Patients with Pulmonary Hypertension Treated with Ritonavir-Boosted Protease Inhibitors
- (2012) Pierangelo Chinello et al. CURRENT HIV RESEARCH
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Hypogonadal Men Nonresponders to the PDE5 Inhibitor Tadalafil Benefit from Normalization of Testosterone Levels with a 1% Hydroalcoholic Testosterone Gel in the Treatment of Erectile Dysfunction (TADTEST Study)
- (2010) Jacques Buvat et al. Journal of Sexual Medicine
- A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects
- (2009) V Sekar et al. CLINICAL DRUG INVESTIGATION
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
- (2009) et al. EUROPEAN HEART JOURNAL
- Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected
- (2009) Sara Åkerström et al. VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now